GENZYME BIOSURGERY CORPORATION – Trademark Portfolio

Entity Type: 03

GENZYME BIOSURGERY CORPORATION holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. The owner is based in RIDGEFIELD, NJ.

65 RAILROAD AVENUE

RIDGEFIELD, NJ 07657

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GENZYME BIOSURGERY CORPORATION's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does GENZYME BIOSURGERY CORPORATION have?

GENZYME BIOSURGERY CORPORATION has 8 U.S. trademarks filed with the USPTO.

What trademark classes does GENZYME BIOSURGERY CORPORATION file in?

GENZYME BIOSURGERY CORPORATION files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is GENZYME BIOSURGERY CORPORATION's trademark registration success rate?

GENZYME BIOSURGERY CORPORATION has a 0% trademark registration rate, with 0 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.